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anglais
Ferrocenyl diphenol tamoxifen derivative (Fc-diOH) is one of the most active
molecules of a new class of organometallic drugs, showing in vitro antiproliferative
effects on both hormone-dependent and independent breast cancer cells. For the
first time, Fc-diOH was tested on a 9L glioma model according to two encapsulation
strategies: lipid nanocapsules (LNC) and swollen micelles. LNC showed a higher
drug loading capacity because of a larger oily core in their structure and were able
to be up taken by glioma cells. The large amount of PEG present at the micellar
interface prevented interaction with cytoplasm membrane which led to a low level of
micelle cell uptake and no biological activity. On the contrary, Fc-diOH cytostatic
activity was conserved after its encapsulation in LNC and was very effective on 9L-
glioma cells as the IC(50) was about 0.6 microM. Interestingly, Fc-diOH-loaded LNC
showed low toxicity levels when in contact with healthy cells, conferring a functional
specificity of this compound on tumour cells. Finally, Fc-diOH LNC treatment was
able to lower significantly both tumour mass and volume evolution after 9L-cell
implantation into rats which evidenced for the first time the in vivo efficacy of this
new kind of organometallic compound.
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